[Federal Register Volume 78, Number 228 (Tuesday, November 26, 2013)]
[Notices]
[Page 70617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-28447]



[[Page 70617]]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


 In the Matter of Pure H20 Bio-Technologies, Inc.; Order of 
Suspension of Trading

November 22, 2013.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Pure H20 Bio-Technologies, Inc. because questions have arisen as to its 
operating status, if any.
    The Commission is of the opinion that the public interest and the 
protection of the investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed company is suspended for the period from 9:30 a.m. EST on 
November 22, 2013, through 11:59 p.m. EST on December 6, 2013.

    By the Commission.
Jill M. Peterson,
Assistant Secretary,
[FR Doc. 2013-28447 Filed 11-22-13; 11:15 am]
BILLING CODE 8011-01-P